Schedule 13D ownership disclosure
INNOVATE BIOPHARMACEUTICALS, INC.
Security class unavailable · CUSIP: 45782F105
Event date: 2018-01-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,990,686
- Percent of class
- 7.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-18-006679
- Form type
- SC 13D
- Filer
- 9 METERS BIOPHARMA, INC.
- CIK
- CIK 1551986
- Filed
- Feb 08, 2018
- Reporting period
- Jan 29, 2018
- Description
- Schedule 13D beneficial ownership